Humanetics Pharmaceuticals Overview
- Year Founded
-
1988
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$8.5M
- Investors
-
6
Humanetics Pharmaceuticals General Information
Description
Operator of a pharmaceutical company intended to develop and commercialize products to enhance human health and well-being. The company focuses on the discovery and early development of drugs that can protect warfighters from the harmful effects of radiation developed for multiple indications utilizing a variety of patented formulations, enabling clinicians to be provided with improved outcomes for cancer patients receiving radiation treatments.
Contact Information
Website
www.humaneticscorp.comCorporate Office
- 261 School Avenue
- Suite 210
- Excelsior, MN 55331
- United States
Corporate Office
- 261 School Avenue
- Suite 210
- Excelsior, MN 55331
- United States
Humanetics Pharmaceuticals Timeline
Humanetics Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Debt - General | 01-Sep-2025 | $8.5M | Completed | Clinical Trials - Phase 2 | ||
| 11. Later Stage VC | Completed | Clinical Trials - Phase 2 | ||||
| 10. Grant | 01-Jan-2023 | Completed | Clinical Trials - Phase 2 | |||
| 9. Grant | 21-Jun-2022 | Completed | Clinical Trials - Phase 2 | |||
| 8. Grant | 01-Jan-2022 | Completed | Clinical Trials - Phase 2 | |||
| 7. Grant | 31-Dec-2019 | Completed | Clinical Trials - Phase 2 | |||
| 6. Grant | 01-Apr-2019 | Completed | Clinical Trials - Phase 2 | |||
| 5. Grant | 01-Dec-2017 | Completed | Clinical Trials - Phase 2 | |||
| 4. Grant | 01-Jan-2016 | $597K | Completed | Clinical Trials - Phase 2 | ||
| 3. Grant | 01-Jan-2014 | $1.72M | Completed | Clinical Trials - Phase 2 |
Humanetics Pharmaceuticals Comparisons
Industry
Financing
Details
Humanetics Pharmaceuticals Competitors (31)
One of Humanetics Pharmaceuticals’s 31 competitors is Renova Therapeutics, a Venture Capital-Backed company based in Carlsbad, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA | ||||
| CSL Behring (Biotechnology) | Corporation | Vienna, Austria | ||||
| Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | ||||
| Cantex Pharmaceuticals | Formerly VC-backed | Weston, FL | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA |
Humanetics Pharmaceuticals Patents
Humanetics Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026169634-A1 | Process for the synthesis of genistein | Pending | 04-Feb-2025 | ||
| US-20240415802-A1 | Genistein for asthma treatment | Pending | 14-Mar-2022 | ||
| US-12797357-B2 | Nanoparticle isoflavone compositions and methods of making and using the same | Active | 10-Feb-2022 | ||
| CA-3207497-A1 | Genistein treatment of inflammatory and immunological disorders | Pending | 11-Jan-2021 | ||
| EP-4274552-A1 | Genistein treatment of inflammatory and immunological disorders | Pending | 11-Jan-2021 | A61K31/352 |
Humanetics Pharmaceuticals Signals
Humanetics Pharmaceuticals Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| United States Department of War | Government | |||
| National Institutes of Health | Government | |||
| National Aeronautics and Space Administration | Government | |||
| National Cancer Institute | Government | |||
| National Institute Of Allergy and Infectious Diseases | Government |
Humanetics Pharmaceuticals Investments (1)
Humanetics Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with DSM Nutritional Products (Drug Manufacturing Assets in the United States). The deal was made on 19-Feb-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| DSM Nutritional Products (Drug Manufacturing Assets in the United States) | 19-Feb-2020 | Corporate Asset Purchase | Buildings and Property |
Humanetics Pharmaceuticals FAQs
-
When was Humanetics Pharmaceuticals founded?
Humanetics Pharmaceuticals was founded in 1988.
-
Where is Humanetics Pharmaceuticals headquartered?
Humanetics Pharmaceuticals is headquartered in Excelsior, MN.
-
What is the size of Humanetics Pharmaceuticals?
Humanetics Pharmaceuticals has 18 total employees.
-
What industry is Humanetics Pharmaceuticals in?
Humanetics Pharmaceuticals’s primary industry is Other Healthcare Technology Systems.
-
Is Humanetics Pharmaceuticals a private or public company?
Humanetics Pharmaceuticals is a Private company.
-
What is Humanetics Pharmaceuticals’s current revenue?
The current revenue for Humanetics Pharmaceuticals is .
-
How much funding has Humanetics Pharmaceuticals raised over time?
Humanetics Pharmaceuticals has raised $8.5M.
-
Who are Humanetics Pharmaceuticals’s investors?
United States Department of War, National Institutes of Health, National Aeronautics and Space Administration, National Cancer Institute, and National Institute Of Allergy and Infectious Diseases are 5 of 6 investors who have invested in Humanetics Pharmaceuticals.
-
Who are Humanetics Pharmaceuticals’s competitors?
Renova Therapeutics, CSL Behring (Biotechnology), Cristal Therapeutics, Cantex Pharmaceuticals, and Genentech are some of the 31 competitors of Humanetics Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process